In 2018, the ASF co-funded a feasibility study to test a newborn screening for Angelman syndrome, Prader-Willi syndrome and dup15q syndrome. As always, we thank our generous donors! Your support and belief in the ASF mission makes it possible […]Read more
2022 ASF Walk
With 50 locations across the US, the ASF Walk is the largest gathering of individuals with AS, their families and community members who support them. Don’t miss it!
The ASF Walk provides individuals with AS, their families and their caregivers with the resources they need to meet their daily challenges. When you participate in the ASF Walk, you’re not only a Game Changer, you’re a Life Changer!
Since her diagnosis, we have relied on the Angelman Syndrome Foundation as a source of information and support.
The Angelman Syndrome Clinic at MGH is a blessing for my adult child. Now we have somebody who really understands our needs.
Amazing things have happened because of the ASF-funded LGIT study from Boston’s MassGeneral Hospital. It was the beginning of a new era for treatments for our children with AS.
IN THE NEWS
Latest press releases, articles and announcements
As part of a 2020 ASF funded study, Ben Philpot, PhD and Matt Judson, PhD at UNC School of Medicine have been developing a gene therapy strategy as a method to restore function of UBE3A. The early results were published […]Read more
The Angelman Syndrome Foundation and Angelman UK announce a new partnership that will increase support to Angelman syndrome families. Angelman UK will fund eligible ASF Family Fund applicants located in the United Kingdom. Angelman UK joins the Canadian Angelman Syndrome […]Read more
FAST, the Foundation for Angelman Syndrome Therapeutics, and ASF, the Angelman Syndrome Foundation, announce a collaboration for a legislative working group focused on furthering the awareness and treatment of Angelman syndrome through legislative advocacy. The legislative working group will continue […]Read more